Hepatitis C virus (HCV) subtypes were determined in 125 Iranian patients by phylogenetic
analysis within the NS5B or 5′‐UTR/core regions. Subtypes 1a and 3a were predominant …

Hepatitis C virus (HCV) has infected approximately 170 million people worldwide. While the
seroprevalence of anti‐HCV antibody among Iranian blood donors is 0.13%, HCV infection …

BACKGROUND: Hepatitis C virus (HCV) is a causative agent of chronic liver disease,
cirrhosis, and hepatocellular carcinoma. In Pakistan, more than 10 million people are living …

ABSTRACT Background/Aims: Hepatitis C virus (HCV) genotyping has a considerable effect
on therapy. The aim was to determine the change in prevalence of HCV genotypes in Turkey …

Egypt is one of the countries with very high rates of hepatitis C virus (HCV) related morbidity
and mortality. However, little is known about geographical and clinical differences in genetic …

Phylogenetic analysis of the sequences of the 5′ noncoding regions (5′ NCR) of 149
samples from hepatitis C virus (HCV) RNA-positive chronic carriers representing northern …

Hepatitis C virus (HCV) strains isolated from 68 haemodialysis Tunisian patients exhibiting
chronic infection were genotyped targeting the NS5b region of the HCV genome using a …

Hepatitis C virus (HCV) shows substantial nucleotide sequence diversity distributed
throughout the viral genome, with many variants showing only 68–79% overall sequence …

Hepatitis C virus (HCV) infection is a major health problem in Egypt, where the
seroprevalence is 10–20-fold higher than that in the United States. To characterize the HCV …

Hepatitis C virus has substantial heterogeneity of genotypes throughout the world. The aim
of this study was to determine the frequency of HCV genotypes, risk factors and clinical …